Functionalized silica matrices for controlled delivery of cephalexin

被引:42
作者
Basaldella, Elena I. [1 ]
Legnoverde, Maria S. [1 ]
机构
[1] UNLP, CIC, CONICET, Dr Jorge J Ronco CINDECA,Ctr Invest & Desarrollo, RA-1900 La Plata, Argentina
关键词
SBA-15; Surface functionalization; Cephalexin; Drug release; MESOPOROUS SILICA; CONTROLLED-RELEASE; DRUG-DELIVERY; SBA-15; CATALYSTS; SIZE;
D O I
10.1007/s10971-010-2293-7
中图分类号
TQ174 [陶瓷工业]; TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The surface of SBA-15 ordered mesoporous silica was functionalized with sulphonic and amine functional groups to determine the effect of changes in surface acidity on cephalexin adsorption and subsequent release. Cephalexin (CPX), which belongs to the group of cephalosporins or beta-lactam antibiotics, was impregnated on functionalized SBA-15. The functionalized silica materials were characterized by SEM, TGA, FTIR and N(2) adsorption, and an in vitro drug delivery test was performed. SEM micrographs showed the packed cylinders correspond to SBA 15 materials. Likewise, N(2) adsorption-desorption isotherms demonstrated that the SBA-15 structure was obtained when IV-type isotherms were displayed. The inalterable stabilization of the drug was confirmed by FTIR spectroscopy. For all the samples studied, the delivery profiles exhibit two steps. A fast initial stage was obtained over the first 5 h, followed by a slower one. Regarding this second stage, the time needed to attain a plateau was undoubtedly altered by the surface functionalization.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 16 条
[1]   Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size, and drug release [J].
Agnihotri, Sunil A. ;
Jawalkar, Sheetal S. ;
Aminabhavi, Tejraj M. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 63 (03) :249-261
[2]  
[Anonymous], 2004, INFRARED SPECTROSCOP, DOI [10.1002/0470011149, DOI 10.1002/0470011149]
[3]   Mesoporous sulfonic acids as selective heterogeneous catalysts for the synthesis of monoglycerides [J].
Bossaert, WD ;
De Vos, DE ;
Van Rhijn, WM ;
Bullen, J ;
Grobet, PJ ;
Jacobs, PA .
JOURNAL OF CATALYSIS, 1999, 182 (01) :156-164
[4]   Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery [J].
Doadrio, AL ;
Sousa, EMB ;
Doadrio, JC ;
Pariente, JP ;
Izquierdo-Barba, I ;
Vallet-Regí, M .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (01) :125-132
[5]   Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern [J].
Doadrio, JC ;
Sousa, EMB ;
Izquierdo-Barba, I ;
Doadrio, AL ;
Perez-Pariente, J ;
Vallet-Regí, M .
JOURNAL OF MATERIALS CHEMISTRY, 2006, 16 (05) :462-466
[6]   A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules [J].
Lai, CY ;
Trewyn, BG ;
Jeftinija, DM ;
Jeftinija, K ;
Xu, S ;
Jeftinija, S ;
Lin, VSY .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (15) :4451-4459
[7]   Blue-shifting photoluminescence of Tris (8-hydroxyquinoline) aluminium encapsulated in the channel of functionalized mesoporous silica SBA-15 [J].
Li, Nan ;
Li, Xiaotian ;
Wang, Wei ;
Geng, Wangchang ;
Qiu, Shilun .
MATERIALS CHEMISTRY AND PHYSICS, 2006, 100 (01) :128-131
[8]   Periodic mesoporous silica and organosilica with controlled morphologies as carriers for drug release [J].
Lin, Chun Xiang ;
Qiao, Shi Zhang ;
Yu, Cheng Zhong ;
Ismadji, Suryadi ;
Lu, Gao Qing .
MICROPOROUS AND MESOPOROUS MATERIALS, 2009, 117 (1-2) :213-219
[9]   Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lobe epilepsy [J].
Lopez, T. ;
Basaldella, E. I. ;
Ojeda, M. L. ;
Manjarrez, J. ;
Alexander-Katz, R. .
OPTICAL MATERIALS, 2006, 29 (01) :75-81
[10]  
López T, 2009, KEY ENG MATER, V391, P169, DOI 10.4028/www.scientific.net/KEM.391.169